Tag: TSXV:LXG

November 26, 2019

LexaGene Eyes Q2 2020 for Commercialization, Builds on Funding

Dr. Jack Regan, CEO and founder of LexaGene, said the company is on pace to become fully commercialized by June...
October 29, 2019

LexaGene Announces Closing of C$6.6 Million Financing

LexaGene Holdings announced it had closed its offering, which totaled 12.7 million units at C$0.52 each for gross proceeds of...
September 18, 2019

LexaGene Tackling Antibiotic Resistance with Genetic Analyzer

The company's device has the capabilities to identify pathogens and antibiotic and antimicrobial resistance in as little as an hour.